News
GSK’s shingles vaccine Shingrix gains UK license
GlaxoSmithKline’s (GSK) Shingrix has been licensed in the UK for the prevention of shingles in adults aged 50 years and older, as well as in adults 18 years of age or older who are at increased risk of shingles.